Integra LifeSciences Holdings Gross Margin 2010-2024 | IART

Current and historical gross margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current gross profit margin for Integra LifeSciences Holdings as of September 30, 2024 is %.
Integra LifeSciences Holdings Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $1.57B $0.86B 54.89%
2024-06-30 $1.57B $0.88B 56.00%
2024-03-31 $1.53B $0.86B 56.12%
2023-12-31 $1.54B $0.88B 57.37%
2023-09-30 $1.54B $0.91B 58.88%
2023-06-30 $1.55B $0.93B 60.00%
2023-03-31 $1.56B $0.97B 62.04%
2022-12-31 $1.56B $0.97B 62.26%
2022-09-30 $1.57B $0.97B 61.88%
2022-06-30 $1.57B $0.97B 62.12%
2022-03-31 $1.56B $0.96B 61.79%
2021-12-31 $1.54B $0.94B 61.18%
2021-09-30 $1.53B $0.94B 61.40%
2021-06-30 $1.51B $0.93B 61.63%
2021-03-31 $1.38B $0.84B 61.25%
2020-12-31 $1.37B $0.85B 62.03%
2020-09-30 $1.38B $0.86B 62.05%
2020-06-30 $1.39B $0.86B 61.72%
2020-03-31 $1.51B $0.94B 62.37%
2019-12-31 $1.52B $0.95B 62.78%
2019-09-30 $1.51B $0.94B 62.68%
2019-06-30 $1.49B $0.93B 62.36%
2019-03-31 $1.48B $0.92B 62.37%
2018-12-31 $1.47B $0.90B 61.28%
2018-09-30 $1.46B $0.89B 60.70%
2018-06-30 $1.37B $0.84B 61.20%
2018-03-31 $1.29B $0.79B 61.62%
2017-12-31 $1.19B $0.75B 63.25%
2017-09-30 $1.08B $0.70B 65.24%
2017-06-30 $1.05B $0.69B 65.52%
2017-03-31 $1.01B $0.66B 65.38%
2016-12-31 $0.99B $0.64B 64.82%
2016-09-30 $0.98B $0.62B 63.87%
2016-06-30 $0.95B $0.60B 63.27%
2016-03-31 $0.92B $0.58B 63.25%
2015-12-31 $0.88B $0.56B 62.85%
2015-09-30 $0.80B $0.50B 62.52%
2015-06-30 $0.77B $0.48B 62.71%
2015-03-31 $0.79B $0.49B 62.17%
2014-12-31 $0.80B $0.49B 61.98%
2014-09-30 $0.73B $0.45B 61.52%
2014-06-30 $0.74B $0.45B 61.22%
2014-03-31 $0.72B $0.43B 60.56%
2013-12-31 $0.70B $0.42B 59.83%
2013-09-30 $0.83B $0.51B 60.84%
2013-06-30 $0.83B $0.51B 61.06%
2013-03-31 $0.83B $0.51B 61.73%
2012-12-31 $0.83B $0.52B 62.41%
2012-09-30 $0.82B $0.51B 61.71%
2012-06-30 $0.81B $0.50B 61.45%
2012-03-31 $0.80B $0.49B 61.26%
2011-12-31 $0.78B $0.48B 61.67%
2011-09-30 $0.77B $0.48B 62.73%
2011-06-30 $0.76B $0.48B 63.05%
2011-03-31 $0.74B $0.47B 63.43%
2010-12-31 $0.73B $0.46B 63.17%
2010-09-30 $0.72B $0.46B 63.62%
2010-06-30 $0.71B $0.45B 63.84%
2010-03-31 $0.70B $0.44B 63.88%
2009-12-31 $0.68B $0.44B 64.13%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.683B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $207.434B 25.31
Intuitive Surgical (ISRG) United States $194.997B 101.95
Edwards Lifesciences (EW) United States $43.303B 27.50
Alcon (ALC) Switzerland $41.141B 27.53
IQVIA Holdings (IQV) United States $36.894B 20.33
IDEXX Laboratories (IDXX) United States $34.232B 40.31
DexCom (DXCM) United States $30.373B 45.74
Waters (WAT) United States $22.584B 33.39
STERIS (STE) Ireland $20.308B 23.38
SONOVA HOLDING (SONVY) Switzerland $19.662B 0.00
Hologic (HOLX) United States $16.272B 17.57
Fresenius Medical Care AG KGaA (FMS) Germany $13.198B 13.55
Globus Medical (GMED) United States $11.856B 30.02
Sysmex ADR (SSMXY) Japan $11.516B 36.11
Penumbra (PEN) United States $9.619B 94.22
Masimo (MASI) United States $8.910B 43.11
Glaukos (GKOS) United States $8.631B 0.00
Teleflex (TFX) United States $8.110B 12.93
Inari Medical (NARI) United States $4.642B 0.00
PROCEPT BioRobotics (PRCT) United States $4.532B 0.00
Integer Holdings (ITGR) United States $4.486B 25.42
Veracyte (VCYT) United States $3.219B 96.60
LivaNova (LIVN) United Kingdom $2.534B 14.63
Nihon Kohden (NHNKY) Japan $2.370B 18.00
Tandem Diabetes Care (TNDM) United States $2.364B 0.00
TransMedics (TMDX) United States $2.309B 73.20
Elekta AB (EKTAY) Sweden $2.138B 19.22
Alphatec Holdings (ATEC) United States $1.414B 0.00
RxSight (RXST) United States $1.347B 0.00
Artivion (AORT) United States $1.253B 83.00
Pulse Biosciences (PLSE) United States $1.136B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.867B 0.00
AxoGen (AXGN) United States $0.794B 0.00
Mesa Laboratories (MLAB) United States $0.730B 17.21
IRadimed (IRMD) United States $0.717B 38.76
AVANOS MEDICAL, INC (AVNS) United States $0.699B 11.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.650B 0.00
OrthoPediatrics (KIDS) United States $0.592B 0.00
SiBone (SIBN) United States $0.575B 0.00
Pacific Biosciences Of California (PACB) United States $0.575B 0.00
AngioDynamics (ANGO) United States $0.498B 0.00
Semler Scientific (SMLR) United States $0.476B 25.05
Treace Medical Concepts (TMCI) United States $0.455B 0.00
Tactile Systems Technology (TCMD) United States $0.413B 22.38
ClearPoint Neuro (CLPT) United States $0.405B 0.00
Delcath Systems (DCTH) United States $0.367B 0.00
NeuroPace (NPCE) United States $0.356B 0.00
CVRx (CVRX) United States $0.344B 0.00
Inogen (INGN) United States $0.227B 0.00
Alpha Tau Medical (DRTS) Israel $0.226B 0.00
Anteris Technologies Global (AVR) Australia $0.216B 0.00
Accuray (ARAY) United States $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Sight Sciences (SGHT) United States $0.165B 0.00
Nevro (NVRO) United States $0.123B 0.00
Atossa Genetics (ATOS) United States $0.114B 0.00
Spectral Diagnostics (EDTXF) Canada $0.111B 0.00
Sensus Healthcare (SRTS) United States $0.107B 11.47
LENSAR (LNSR) United States $0.096B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
908 Devices (MASS) United States $0.079B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
Vicarious Surgical (RBOT) United States $0.074B 0.00
InspireMD (NSPR) Israel $0.072B 0.00
Hyperfine (HYPR) United States $0.069B 0.00
WORK Medical Technology Group (WOK) China $0.063B 0.00
Covalon Technologies (CVALF) Canada $0.061B 31.57
Baird Medical Investment Holdings (BDMD) $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.057B 0.00
Neuronetics (STIM) United States $0.052B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Rapid Micro Biosystems (RPID) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Microbot Medical (MBOT) United States $0.039B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
NexGel (NXGL) United States $0.023B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Adagio Medical Holdings (ADGM) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
Aspira Women's Health (AWH) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Check-Cap (CHEK) Israel $0.009B 0.00
PAVmed (PAVM) United States $0.007B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00